Eco Animal Health Gets Canadian Marketing Authorisation For Aivlosin

Mon, 03rd Feb 2014 10:22

LONDON (Alliance News) - Eco Animal Health Group PLC said Monday that it had been granted marketing authorisation by the Veterinary Drugs Director of Health Canada for its in-feed pig medication Aivlosin 17% premix.

The Aivlosin 17% premix will be marketed for the treatment of porcine proliferative enteropathy, an intestinal disease in pigs. Aivolsin is also used to treat respiratory and intestinal diseases in pigs and poultry.

Shares in Eco Animal Health were trading up 0.7% at 210.50 pence Monday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Related Shares

More News

25 Apr 2024 16:00

EARNINGS AND TRADING: ECO Animal revenue up; Zephyr starts drilling

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance New...

25 Apr 2024 10:16

Eco Animal Health revenue set to top expectations

(Sharecast News) - Eco Animal Health said in an update on Thursday that, despite initial foreign exchange challenges, its revenue for the year surpass...

4 Apr 2024 14:04

ECO Animal Health streamlines product portfolio with disposal

(Alliance News) - ECO Animal Health Group PLC said on Thursday that it had disposed of one of its non-core product lines.

4 Apr 2024 11:57

Eco Animal Health sells equine parasite treatment for EUR 1.3m

(Sharecast News) - Eco Animal Health announced the sale of 'ECOmectin Horsepaste' to its manufacturing partner Acme Drugs in Italy on Thursday, for to...

21 Mar 2024 19:05

EARNINGS AND TRADING: Getech confident; Aukett Swanke makes buy

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...